Nutex Net Receivables from 2010 to 2024

NUTX Stock  USD 34.76  0.54  1.58%   
Nutex Health Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables will likely drop to about 41.9 M in 2024. During the period from 2010 to 2024, Nutex Health Net Receivables regression line of annual values had r-squared of  0.50 and arithmetic mean of  28,177,921. View All Fundamentals
 
Net Receivables  
First Reported
2010-03-31
Previous Quarter
65.2 M
Current Value
62.7 B
Quarterly Volatility
10.6 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 26.3 M, Total Revenue of 129 M or Gross Profit of 54.7 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0037 or PTB Ratio of 1.84. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.
  
Check out the analysis of Nutex Health Correlation against competitors.
For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Latest Nutex Health's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Nutex Health over the last few years. It is Nutex Health's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Nutex Net Receivables Regression Statistics

Arithmetic Mean28,177,921
Geometric Mean661,690
Coefficient Of Variation144.95
Mean Deviation33,725,317
Median186,150
Standard Deviation40,843,832
Sample Variance1668.2T
Range114.8M
R-Value0.71
Mean Square Error891.9T
R-Squared0.50
Significance0
Slope6,480,700
Total Sum of Squares23355.1T

Nutex Net Receivables History

202441.9 M
202362.8 M
202258.3 M
2021114.8 M
2020108.1 M
201936.1 M
2018186.2 K

About Nutex Health Financial Statements

Nutex Health investors use historical fundamental indicators, such as Nutex Health's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables62.8 M41.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.